Maximum Fair Pricing: Impact on Retail Pharmacies

Maximum Fair Pricing (MFP) took effect Jan. 1, 2026, bringing a historic shift to Medicare drug reimbursement. While the program’s intent is positive—to lower drug costs for Medicare patients—it also introduces new pricing and payment requirements that can add complexity to pharmacy operations.

For many owners and managers, the question isn’t whether MFP will impact the business—it’s how prepared your pharmacy is to adapt. This guide outlines key changes, emerging pressure points, and steps you can take now to stay ahead.

What Is MFP—and Why Does It Matter?

MFP is a provision of the Inflation Reduction Act (IRA) designed to establish fair, lower prices for certain medications commonly used by Medicare recipients. Through negotiation with drug manufacturers, Medicare sets a capped price—the Maximum Fair Price—that it will pay for select medications.

For independent pharmacies, this can mean a potential shift in revenue—especially those serving large Medicare populations—and a need to adapt workflows to include rebate processing, new reporting, and reimbursement tracking.